Brief: Nexalin Technology Announces Additional Positive Clinical Results In Alzheimer’S Disease With Gen-2 Sync Neurostimulation Device
08/10/2025 14:01
Oct 8 (Reuters) - Nexalin Technology Inc NXL.O: NEXALIN TECHNOLOGY ANNOUNCES ADDITIONAL POSITIVE CLINICAL RESULTS IN ALZHEIMER’S DISEASE WITH GEN-2 SYNC NEUROSTIMULATION DEVICE NEXALIN TECHNOLOGY INC - NO ADVERSE EVENTS REPORTED FOR NEXALIN'S DIFS TECHNOLOGY Source text: ID:nGNX6JXqdr Further company coverage: NXL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nexalin Technology
See all newsBrief: Nexalin Technology Regains Compliance With Nasdaq Minimum Bid Price Requirement Nasdaq Hearings Panel Grants Request For Continued Listing
NASDAQ RESUMED AT 12:48 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM
NASDAQ RESUMED AT 10:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:24 AM